Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity
Daniel J. Cuthbertson (Lead / Corresponding author), John Babraj, Graham Leese, Mario Siervo
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity'. Together they form a unique fingerprint.